U.S. to procure additional 100 million doses of J&J COVID-19 vaccine:
official
Send a link to a friend
[March 10, 2021]
WASHINGTON (Reuters) - The United States
plans to double its order of the single-shot Johnson & Johnson
coronavirus vaccine, procuring an additional 100 million doses, a White
House official said on Wednesday.
|
President Joe Biden will make the announcement at a meeting with the
chief executives of J&J and Merck & Co later in the day, the
official said. Merck has agreed to partner with J&J to produce its
vaccine.
J&J’s manufacturing has been slower than expected, and the company
was not expected to be able to deliver any doses of its vaccine this
week. It is expected to resume shipments later in March.
(Reporting by Steve Holland; Writing by Doina Chiacu;; editing by
John Stonestreet)
[to top of second column]
 |

[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |